Synapse - Works

Results (936)

A phase 2, open-label, adaptive, dose-ranging study with long-term extension to evaluate the safety, tolerability, efficacy, and pharmacokinetics of intra-articular AMB-05X injections in patients with tenosynovial giant cell tumor

Meeting Abstract

Gelderblom, H.; Bhadri, V.; Randall, R. L.; Scharschmidt, T.; Tap, W. D.; Alani, L.; Johnson, K.; Leyva, S.; Nguyen, D. D.; Nguyen, T.; more...
Journal of Clinical Oncology (2023)

Fulltext@MSK | Save

NOTOS: A pivotal study of navtemadlin, a first-in-class mouse double minute 2 inhibitor (MDM2i), in patients (pts) with TP53 wild-type (TP53(WT)) Merkel cell carcinoma (MCC) for whom anti PD-1/L1 therapy has failed

Meeting Abstract

Wong, M. K. K.; Burgess, M. A.; Chandra, S.; Fecher, L. A.; Gaudy-Marqueste, C.; Silk, A. W.; Hanna, G. J.; Lebbe, C.; Quéreux, G.; Rabinowits, G.; more...
Journal of Clinical Oncology (2023)

Fulltext@MSK | Save

Survivorship in patients with cardiac metastases defined by cardiac magnetic resonance imaging in relation to lesion hypoperfusion

Meeting Abstract

Jain, R.; Liberman, N.; Agoglia, H.; Park, M.; Park, R.; Jessurun, J.; Tap, W. D.; Kim, J.; Steingart, R.; Liu, J.; more...
Journal of Clinical Oncology (2023)

Fulltext@MSK | Save

Initial results from the phase (ph) 1 portion of a ph 1/2 study of THE-630 in patients (pts) with advanced gastrointestinal stromal tumor (GIST)

Meeting Abstract

George, S.; Tap, W. D.; von Mehren, M.; Gordon, M. S.; Trent, J. C.; Attia, S.; Zhang, S.; Narasimhan, N.; Rivera, V. M.; Kerstein, D.; more...
Journal of Clinical Oncology (2023)

Fulltext@MSK | Save

Real-world utilization pattern of pexidartinib in patients with tenosynovial giant cell tumor (TGCT)

Meeting Abstract

Lin, F.; Tse, J.; Shaikh, N. F.; Wang, E. J.; Near, A.; Kwong, J.; Tap, W. D.
Journal of Clinical Oncology (2023)

Fulltext@MSK | Save

The SPEARHEAD-1 trial of afamitresgene autoleucel (afami-cel [formerly ADP-A2M4]): Pooled analysis of cytokine release syndrome across cohorts in patients with advanced synovial sarcoma

Meeting Abstract

D'Angelo, S. P.; Ganjoo, K. N.; Blay, J. Y.; Valverde, C.; Araujo, D. M.; Abdul Razak, A. R.; Le Cesne, A.; Schuetze, S.; Wagner, M. J.; Attia, S.; more...
Journal of Clinical Oncology (2023)

Fulltext@MSK | Save

A phase 2 study of alrizomadlin, a novel MDM2/p53 inhibitor, in combination with pembrolizumab for treatment of patients with malignant peripheral nerve sheath tumor (MPNST)

Meeting Abstract

Somaiah, N.; Van Tine, B. A.; Chmielowski, B.; Drabick, J. J.; Chawla, S. P.; McKean, M.; Spira, A. I.; O'Byrne, K. J.; Foresto, S. A.; Movva, S.; more...
Journal of Clinical Oncology (2023)

Fulltext@MSK | Save

The SPEARHEAD-1 trial of afamitresgene autoleucel (afami-cel [formerly ADP-A2M4]): Analysis of overall survival in advanced synovial sarcoma

Meeting Abstract

Van Tine, B. A.; Ganjoo, K. N.; Blay, J. Y.; Valverde, C.; Araujo, D. M.; Abdul Razak, A. R.; Le Cesne, A.; Schuetze, S.; Wagner, M. J.; Attia, S.; more...
Journal of Clinical Oncology (2023)

Fulltext@MSK | Save

Impact of nirogacestat on pain, a key symptom in patients with desmoid tumors (DT): Results from the phase 3 DeFi study

Meeting Abstract

Van Der Graaf, W. T. A.; Gounder, M. M.; Ratan, R.; Ivanescu, C.; Marcus, J.; Bell, T.; Lim, A.; Smith, L. M.; Oton, A. B.; Alcindor, T.; more...
Journal of Clinical Oncology (2023)

Fulltext@MSK | Save

A phase II study of talimogene laherparepvec (T-VEC) and pembrolizumab in patients with advanced sarcoma: Results of expansion cohorts

Meeting Abstract

Kelly, C. M.; Avutu, V.; Chi, P.; Dickson, M. A.; Gounder, M. M.; Keohan, M. L.; Movva, S.; Rosenbaum, E.; Cordover, E.; Ariyan, C. E.; more...
Journal of Clinical Oncology (2023)

Fulltext@MSK | Save